-
Mashup Score: 0
Thomas Cluzeau, MD, PhD, University Hospital of Nice, Nice, France, discusses current clinical indications for the use of CPX-351 in…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY, gives an overview of novel combinations being…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
There are several interesting combinations being explored in AML using an HMA-ven backbone, including FLT3 inhibitors, IDH inhibitors & ADCs. Find out more in our interview with @mkonople of @EinsteinMed: 👉https://t.co/wcdzSEuyz6👈 #AMLsm #LeuSM #HemOnc #ISAL2023
-
-
Mashup Score: 1Clonal hematopoiesis in AML & insights into a novel CHIP risk stratification score being explored - 1 year(s) ago
Benjamin Ebert, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, shares some insights into clonal hematopoiesis of indeterminate potential (CHIP) and…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Benjamin Ebert (@DanaFarber) shares some insights into clonal hematopoiesis & its association with other inflammatory diseases, a novel CHIP risk stratification score, and more! Watch here: 🎥 https://t.co/VqmHftZqS5 #ISAL2023 #AMLsm #LeuSM #HemOnc
-
-
Mashup Score: 1Acute Myeloid Leukemia - VJHemOnc - 1 year(s) ago
Explore the latest Acute Myeloid Leukemia updates and expert interviews on The AML Channel from VJHemOnc
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Pleasure to speak with Peter van Galen (@vangalenlab; @BrighamHeme) here at #ISAL2023 on investigating AML using single-cell technologies & more! For the latest AML updates, visit: 👉https://t.co/ItYLjLcYGx👈 #AMLsm #LeuSM #HemOnc https://t.co/fuLOcsCQrJ
-
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 1 year(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Stone (@DanaFarber) shared some insights into the management of patients with FLT3-ITD AML, updates in the risk stratification & prognosis of AML, & more. Stay tuned for our interviews on https://t.co/Unq3XaxzpH! #ISAL2023 #LeuSM #AMLsm #HemOnc https://t.co/rTybHYG1dE
-
-
Mashup Score: 0The molecular impact of RUNX1 mutations in AML - 1 year(s) ago
In this video, Constanze Bonifer, PhD, University of Birmingham, Birmingham, UK, discusses the impact of RUNX1 mutations in acute myeloid…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Find out more about the molecular impact of RUNX1 mutations in AML in our exclusive interview with Constanze Bonifer (@unibirmingham): 👉https://t.co/FGpbFHsUyA👈 #ISALXVIII #ISAL2023 #AMLsm #LeuSM #HemOnc
-
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 1 year(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A very insightful interview with @RaviMajetiMD (@stanford) on the challenges of targeting leukemic stem cells in AML, the promise of TR-APCs as a potential novel therapeutic strategy, & more. Check out our interviews on https://t.co/Unq3XaxzpH! #AMLsm #LeuSM #ISAL2023 https://t.co/tyOBXwZdm5
-
-
Mashup Score: 0ISAL 2023 | VJHemOnc - 1 year(s) ago
The 18th International Symposium on Acute Leukemias 19–22 March 2023 | Munich, Germany / Online The 18th International Symposium on Acute Leukemias (ISALXVIII) is taking place on March 19-22 2023 in Munich, Germany, and online, and will cover the most exciting updates in the biology and treatment of acute…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Started off our first round of interviews this morning at #ISAL2023 with Irmela Jeremias (@helmholtz_de, @LMU_Muenchen), who spoke on functional diversity in leukemic stem cells & the heterogeneity of AML. Check out our interviews on https://t.co/YpiZl4sLFU #AMLsm #LeuSM… https://t.co/mNH74wYvVk https://t.co/cU4UWyvn2X
-
-
Mashup Score: 0ISAL 2023 | VJHemOnc - 1 year(s) ago
The 18th International Symposium on Acute Leukemias 19–22 March 2023 | Munich, Germany / Online The 18th International Symposium on Acute Leukemias (ISALXVIII) is taking place on March 19-22 2023 in Munich, Germany, and online, and will cover the most exciting updates in the biology and treatment of acute…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Tune in for another exciting day in Munich as we continue to share the latest updates in AML and ALL from #ISAL2023! Check out our interviews here: 👉https://t.co/eoEhDDJGoh👈 #AMLsm #ALLsm #LeuSM #HemOnc #ImmunoOnc #ISALXVIII https://t.co/BT3ckYllSM
-
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 1 year(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A really insightful discussion here at #ISAL2023 with experts @charliecraddock & @DrChrisHourigan, who spoke on pre-transplant MRD, novel technologies, the prognostic impact of MRD in AML & more! Stay tuned for more on https://t.co/Unq3XaxzpH! #LeuSM #AMLsm #HemOnc https://t.co/fSOaMtdqUp
-
Want to find out more about the role of CPX-351 in AML and ongoing trials evaluating this agent? @thomas_cluzeau of @CHUdeNice shares some insights: 🎥 https://t.co/XintIItbaH #AMLsm #LeuSM #HemOnc #ISAL2023